• Users Online: 67960
  • Home
  • Print this page
  • Email this page

    Article Cited by others

LETTER TO THE EDITOR

Intravitreal bevacizumab for subfoveal choroidal neovascularization complicating active central serous chorioretinopathy

Mandal Subrata, Sinha Subijay, Abbas Zahir, Venkatesh Pradeep

Year : 2011| Volume: 59| Issue : 4 | Page no: 338-339

   This article has been cited by
 
1 Central Serous Chorioretinopathy: An Update on the Current State of Management
Dimitrios Kalogeropoulos, Lincoln Shaw, Dimitra Skondra, Aikaterini Christodoulou, Chris Kalogeropoulos
Klinische Monatsblätter für Augenheilkunde. 2023;
[Pubmed]  [Google Scholar] [DOI]
2 Ranibizumab Treatment for Choroidal Neovascularization Secondary to Causes Other than Age-Related Macular Degeneration with Good Baseline Visual Acuity
Muhammet Kazim Erol,Ozdemir Ozdemir,Deniz Turgut Coban,Basak Bostanci Ceran,Mehmet Bulut
Seminars in Ophthalmology. 2014; : 1
[Pubmed]  [Google Scholar] [DOI]
3 Central Serous Chorioretinopathy: Update on Pathophysiology and Treatment
Benjamin Nicholson,Jason Noble,Farzin Forooghian,Catherine Meyerle
Survey of Ophthalmology. 2013; 58(2): 103
[Pubmed]  [Google Scholar] [DOI]

 

Read this article